Jacobs Levy Equity Management, Inc Gossamer Bio, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $23.9 Billion
  • Q3 2025

A detailed history of Jacobs Levy Equity Management, Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,408,118 shares of GOSS stock, worth $3.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,408,118
Previous 1,091,564 29.0%
Holding current value
$3.82 Million
Previous $1.34 Million 175.93%
% of portfolio
0.02%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025
BUY
$1.21 - $3.46 $383,030 - $1.1 Million
316,554 Added 29.0%
1,408,118 $3.7 Million
Q2 2025

Aug 14, 2025
BUY
$0.78 - $1.44 $631,254 - $1.17 Million
809,300 Added 286.72%
1,091,564 $1.34 Million
Q1 2025

May 15, 2025
SELL
$0.85 - $1.53 $1.06 Million - $1.92 Million
-1,252,404 Reduced 81.61%
282,264 $310,000
Q4 2024

Feb 14, 2025
SELL
$0.66 - $1.07 $232,877 - $377,543
-352,844 Reduced 18.69%
1,534,668 $1.38 Million
Q3 2024

Nov 14, 2024
BUY
$0.79 - $1.25 $349,887 - $553,618
442,895 Added 30.66%
1,887,512 $1.87 Million
Q2 2024

Aug 14, 2024
SELL
$0.51 - $1.27 $96,628 - $240,623
-189,467 Reduced 11.59%
1,444,617 $1.3 Million
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $375,171 - $708,135
-468,964 Reduced 22.3%
1,634,084 $1.93 Million
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $1.01 Million - $2.27 Million
2,103,048 New
2,103,048 $1.91 Million
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $3.66 Million - $6.11 Million
-612,496 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$8.44 - $12.49 $2.5 Million - $3.7 Million
-295,936 Reduced 32.58%
612,496 $5.32 Million
Q4 2021

Feb 14, 2022
SELL
$10.12 - $14.07 $697,581 - $969,859
-68,931 Reduced 7.05%
908,432 $10.3 Million
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $211,091 - $385,204
-29,116 Reduced 2.89%
977,363 $12.3 Million
Q2 2021

Aug 16, 2021
SELL
$8.0 - $9.75 $432,600 - $527,231
-54,075 Reduced 5.1%
1,006,479 $8.17 Million
Q1 2021

May 17, 2021
BUY
$8.63 - $10.94 $3.7 Million - $4.7 Million
429,272 Added 68.0%
1,060,554 $9.81 Million
Q4 2020

Feb 16, 2021
SELL
$8.3 - $13.59 $125,587 - $205,630
-15,131 Reduced 2.34%
631,282 $6.1 Million
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $4.34 Million - $5.66 Million
383,635 Added 145.99%
646,413 $8.02 Million
Q2 2020

Aug 17, 2020
BUY
$9.52 - $15.98 $1.62 Million - $2.72 Million
170,045 Added 183.37%
262,778 $3.42 Million
Q1 2020

May 15, 2020
BUY
$8.0 - $15.48 $91,744 - $177,524
11,468 Added 14.11%
92,733 $941,000
Q4 2019

Feb 14, 2020
BUY
$14.82 - $26.79 $1.2 Million - $2.18 Million
81,265 New
81,265 $1.27 Million

Others Institutions Holding GOSS

# of Institutions
179
Shares Held
163M
Call Options Held
8.11M
Put Options Held
211K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $255M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email